- Home
- IVDA vs MBIO Comparison
IVDA vs MBIO Comparison
Compare IVDA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- MBIO
- Stock Information
- Founded
- IVDA 2003
- MBIO 2015
- Country
- IVDA United States
- MBIO United States
- Employees
- IVDA N/A
- MBIO N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- MBIO Health Care
- Exchange
- IVDA Nasdaq
- MBIO Nasdaq
- Market Cap
- IVDA 9.3M
- MBIO 9.1M
- IPO Year
- IVDA N/A
- MBIO N/A
- Fundamental
- Price
- IVDA $3.17
- MBIO $0.17
- Analyst Decision
- IVDA
- MBIO Strong Buy
- Analyst Count
- IVDA 0
- MBIO 1
- Target Price
- IVDA N/A
- MBIO $2.00
- AVG Volume (30 Days)
- IVDA 598.8K
- MBIO 607.5K
- Earning Date
- IVDA 11-14-2024
- MBIO 11-08-2024
- Dividend Yield
- IVDA N/A
- MBIO N/A
- EPS Growth
- IVDA N/A
- MBIO N/A
- EPS
- IVDA N/A
- MBIO N/A
- Revenue
- IVDA $5,305,155.00
- MBIO N/A
- Revenue This Year
- IVDA $23.76
- MBIO N/A
- Revenue Next Year
- IVDA $229.89
- MBIO N/A
- P/E Ratio
- IVDA N/A
- MBIO N/A
- Revenue Growth
- IVDA N/A
- MBIO N/A
- 52 Week Low
- IVDA $1.27
- MBIO $0.13
- 52 Week High
- IVDA $10.16
- MBIO $1.53
- Technical
- Relative Strength Index (RSI)
- IVDA 70.54
- MBIO 32.12
- Support Level
- IVDA $1.93
- MBIO $0.16
- Resistance Level
- IVDA $2.16
- MBIO $0.21
- Average True Range (ATR)
- IVDA 0.38
- MBIO 0.02
- MACD
- IVDA 0.14
- MBIO -0.00
- Stochastic Oscillator
- IVDA 65.45
- MBIO 18.17
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.